France, UK Step Up Efforts To Stem Medication Errors
Executive Summary
France is building on efforts to reduce the risk of medication errors by producing guidance on product labeling and choice of drug names, while the UK is to allow hospitals to access prescribing data from a patient’s doctor when they are taken into hospital to help determine whether the medicines they have taken have led to their admission.
You may also be interested in...
Tackling The High Rejection Rate For Invented Names In The EU
Despite a revamp of the EU guideline on choosing a brand name for a new drug, more names continue to be rejected than accepted. The Pink Sheet’s Ian Schofield spoke to Alexios Skarlatos, the chair of the Name Review Group at the European Medicines Agency, and Jose Ferrero, a scientific administrator at the agency, to find out why and what can be done to improve things. It’s a lot more complex than you might think.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.